Stockscreener 앱 받기
17.50
0.29%
0.05
시간 외 거래:
17.00
-0.50
-2.86%
Grail Inc 주식(GRAL)의 최신 뉴스
Blood test that can screen for 50+ cancers now for sale in Canada, at $2,099 - CBC.ca
Grail initiated at equal weight by Morgan Stanley - MSN
Grail initiated at equal weight by Morgan Stanley (NASDAQ:GRAL) - Seeking Alpha
Morgan Stanley cautious on GRAIL stock despite $100B market opportunity - Investing.com
Grail (NASDAQ:GRAL) Coverage Initiated by Analysts at Morgan Stanley - MarketBeat
Golden Grail Beverages Cancels Convertible Debt to Reduce Dilution - Yahoo Finance
Grail's CFO Aaron Freidin sells $426,937 in common stock By Investing.com - Investing.com South Africa
Grail's CFO Aaron Freidin sells $426,937 in common stock - Investing.com
GRAIL to Participate in Upcoming Investor Conferences - WV News
Golden Grail Beverages CEO Shares Global Vision in New Interview with SmallCapVoice.com - Yahoo Finance
GRAIL to Present at Piper Sandler and Evercore ISI Healthcare Conferences in December | GRAL Stock News - StockTitan
GRAIL uses lung cancer blood test to determine who needs post-surgery therapy most - Mugglehead
Grail tests first patient for TROPION-Lung12 Phase 3 study - TipRanks
GRAIL Launches FDA-Approved Phase 3 Trial for Breakthrough Lung Cancer Blood Test | AZN Stock News - StockTitan
GRAIL Launches FDA-Approved Phase 3 Trial for Breakthrough Lung Cancer Blood Test | DSNKY Stock News - StockTitan
(GRAL) Trading Report - Stock Traders Daily
Wolfe Research Begins Coverage on Grail (NASDAQ:GRAL) - MarketBeat
Wolfe starts Grail at Peer Perform on time and money needs - TipRanks
Grail initiated with a Peer Perform at Wolfe Research - Nasdaq
Golden Grail Beverages Corp. (OTC: GOGY) Retains SmallCapVoice.com Inc. - The Manila Times
Golden Grail Beverages Slashes Share Count 90%, Plans Strategic Acquisitions for 2025 | GOGY Stock News - StockTitan
GRAIL Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
PRIMECAP Management's Strategic Acquisition of GRAIL Inc Shares - GuruFocus.com
Grail Inc. Reports Strong Galleri Test Growth in Q3 2024 - Nasdaq
GRAIL, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
GRAIL Inc Reports Q3 2024 Revenue of $28.7 Million with Signific - GuruFocus.com
GRAIL Reports Third Quarter 2024 Financial Results - PR Newswire
Quantune joins quest for the holy grail of non-invasive glucose monitoring - TechCrunch
How to Take Advantage of moves in (GRAL) - Stock Traders Daily
Grail (GRAL) Scheduled to Post Earnings on Tuesday - MarketBeat
GRAIL to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum - PR Newswire
Jim Cramer says Reddit’s surge is about ‘raw user power,’ calls it ‘holy grail’ for advertisers - CNBC
GRAIL to Announce Third Quarter 2024 Financial Results - StockTitan
(GRAL) Trading Advice - Stock Traders Daily
Google: The Bullish Pivot Before The Earnings Grail (NASDAQ:GOOG) - Seeking Alpha
GRAIL’s woes raise questions about the prospects of MCDs and standards for their evaluation - The Cancer Letter
Nike x Wu-Tang Clan Reunite to Release Legendary Sneaker Grail — NIKE, Inc. - Nike
Illumina Wins Court Fight With EU Over $7 Billion Grail Deal - MSN
Real-world study of Grail’s Galleri consistent with trial data - BioWorld Online
The Jeff Bezos-backed cancer treatment company is being sold for eight billion dollars - Telegrafi
GRAIL Presents Initial Results From REFLECTION Real-World Evidence Study of Galleri® Multi-Cancer Early Detection (MCED) Test at the Early Detection of Cancer Conference - PR Newswire
Health Beat: The 'holy grail' of cancer screening - 69News WFMZ-TV
CEO & Director Of GRAIL Sold 51% Of Their Shares - Simply Wall St
Company commits not to try to crack ‘holy grail’ cement-free formula - Irish Independent
Grail appoints healthcare veteran Sarah Krevans to board By Investing.com - Investing.com Australia
Grail appoints healthcare veteran Sarah Krevans to board - Investing.com
GRAIL Appoints Sarah Krevans to Board of Directors - Quantisnow
Layoff Tracker: Takeda Cuts More Employees, Total Exceeds 1,300 in 2024 - BioSpace
Grail CEO Robert Ragusa sells $1.73 million in stock - Investing.com
How the (GRAL) price action is used to our Advantage - Stock Traders Daily
Health Headlines: Holy Grail of cancer screening - KPLC
GRAIL, Inc. (GRAL): Jeff Bezos Is Buying This Stock Now - Insider Monkey
0.41%
0.63%
자본화:
|
볼륨(24시간):